{"id":"https://openalex.org/W126775747","doi":null,"title":"Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases.","display_name":"Risperidone augmentation of specific serotonin reuptake inhibitors in the treatment of refractory obsessive-compulsive disorder: report of two cases.","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W126775747","mag":"126775747","pmid":"https://pubmed.ncbi.nlm.nih.gov/11725630"},"language":"en","primary_location":{"id":"pmid:11725630","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11725630","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chang Gung medical journal","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072949478","display_name":"Tzu-Kuan Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3020100970","display_name":"Chang Gung Memorial Hospital","ror":"https://ror.org/02verss31","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I3020100970"]},{"id":"https://openalex.org/I4210093821","display_name":"Kaohsiung Chang Gung Memorial Hospital","ror":"https://ror.org/00k194y12","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210093821"]}],"countries":["TW"],"is_corresponding":false,"raw_author_name":"T F Sun","raw_affiliation_strings":["Department of Psychiatry, Chang Gung Memorial Hospital, 123, Ta-Pei Road, Niaosung, Kaohsiung, Taiwan, R.O.C"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Chang Gung Memorial Hospital, 123, Ta-Pei Road, Niaosung, Kaohsiung, Taiwan, R.O.C","institution_ids":["https://openalex.org/I3020100970","https://openalex.org/I4210093821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109865822","display_name":"P-Y Lin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Y Lin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5069377916","display_name":"Cho\u2010Kai Wu","orcid":"https://orcid.org/0000-0002-3867-150X","observed_orcids":["https://orcid.org/0000-0002-3867-150X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C K Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4401,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.66349379,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"24","issue":"9","first_page":"587","last_page":"92"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9070000052452087},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.8539999723434448},{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":0.8309999704360962},{"id":"https://openalex.org/keywords/refractory-obsessive-compulsive-disorder","display_name":"refractory obsessive-compulsive disorder","score":0.8410000205039978},{"id":"https://openalex.org/keywords/antipsychotic-augmentation","display_name":"antipsychotic augmentation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.7739999890327454},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8769999742507935},{"id":"https://openalex.org/keywords/y-bocs","display_name":"Yale-Brown Obsessive Compulsive Scale","score":0.9210000038146973}],"concepts":[{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.9038277864456177},{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.8444992303848267},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7507010698318481},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.7431607246398926},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.7387419939041138},{"id":"https://openalex.org/C3017582312","wikidata":"https://www.wikidata.org/wiki/Q178190","display_name":"Obsessive compulsive","level":2,"score":0.5512453317642212},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.546903133392334},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.5101564526557922},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4619385004043579},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4534386396408081},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.408794105052948},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3169006407260895},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.26735997200012207},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.2559152841567993},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.153458833694458},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:11725630","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11725630","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chang Gung medical journal","raw_type":"Case Reports"},{"id":"mag:126775747","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11725630","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2367662090","https://openalex.org/W183177044","https://openalex.org/W2989970325","https://openalex.org/W7218308072","https://openalex.org/W2108301226","https://openalex.org/W2100202859","https://openalex.org/W2056932759","https://openalex.org/W1966161934","https://openalex.org/W141608893","https://openalex.org/W1963819725"],"abstract_inverted_index":{"The":[0],"efficacy":[1],"of":[2,11,22,35,42,47,56,66,76,175,184,204],"specific":[3],"serotonin":[4],"reuptake":[5],"inhibitors":[6],"(SSRI)":[7],"in":[8,44,73,151],"the":[9,40,45,54,74,104,158,187],"treatment":[10,46,75,214],"obsessive-compulsive":[12,49,78,153],"disorder":[13,50],"(OCD)":[14],"has":[15,37],"been":[16],"established,":[17],"but":[18],"more":[19],"than":[20],"40%":[21],"patients":[23,120,147],"continue":[24],"to":[25,30,39,53,94,109,123,128,171],"have":[26,124],"a":[27,70,91,125,208],"poor":[28,92,107,126],"response":[29,93,108,127],"SSRI.":[31],"Low-dose":[32],"antipsychotic":[33,64],"augmentation":[34,65,203],"SSRI":[36,67,205],"contributed":[38],"amelioration":[41],"symptoms":[43,154],"refractory":[48,77,217],"patients.":[51],"Due":[52],"risk":[55],"side":[57],"effects":[58],"from":[59],"traditional":[60],"antipsychotics,":[61],"atypical":[62],"novel":[63],"may":[68,206],"be":[69,207],"good":[71,209],"choice":[72,210],"disorder.":[79],"Herein":[80],"we":[81],"report":[82],"our":[83],"experience":[84],"with":[85,90,106],"two":[86,188],"OCD":[87,119],"patients,":[88],"one":[89],"fluoxetine":[95,110],"80":[96],"mg":[97,112,131,166,178],"per":[98,113,132,167,179],"day":[99,114,133,168],"for":[100,115,134,216],"3":[101,116],"months,":[102],"and":[103,196,211],"other":[105],"60":[111,130,177],"months.":[117],"Both":[118,146],"also":[121],"proved":[122],"paroxetine":[129,176],"6":[135],"weeks.":[136],"Neither":[137],"patient":[138],"had":[139,192],"received":[140],"any":[141],"psychotherapy":[142],"or":[143],"behavioral":[144],"therapy.":[145],"showed":[148],"significant":[149],"improvement":[150],"their":[152,172],"as":[155],"measured":[156],"by":[157,194],"Yale-Brown":[159],"Obsessive-Compulsive":[160],"Scale":[161],"(Y-BOCS),":[162],"after":[163],"risperidone":[164,202],"1":[165],"was":[169],"added":[170],"on-going":[173],"use":[174],"day.":[180],"Within":[181],"4":[182],"weeks":[183],"adding":[185],"risperidone,":[186],"patients'":[189],"Y-BOCS":[190],"scores":[191],"decreased":[193],"57%":[195],"53%.":[197],"This":[198],"result":[199],"suggests":[200],"that":[201],"an":[212],"effective":[213],"strategy":[215],"OCD.":[218]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
